Which of the following statements is not true about adenomas: they are most commonly seen in menopausal women, prior or current use of estrogen (estrogen) is a risk factor, they are soft, encapsulated and are tan to light brown, or they are typically solitary?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Adenomas

The statement that is NOT true about adenomas is that they are most commonly seen in menopausal women. 1

Epidemiology and Demographics of Adenomas

  • Pituitary adenomas are very rare before puberty, with prolactinomas being the most common type in children and young people (CYP) under 19 years of age 1
  • Pituitary adenomas occur approximately 3-4.5 times more frequently in females than males 1
  • Adenomas typically present during adolescence, not during menopause, with median duration of symptom history before diagnosis being about 12 months 1
  • In postmenopausal women, the most common solid adnexal mass is a pedunculated leiomyoma (fibroid), not an adenoma 1

Risk Factors for Adenomas

  • Prior or current use of estrogen is indeed a risk factor for adenomas, particularly hepatocellular adenomas 2, 3
  • Exogenous estrogen is associated with growth of hepatocellular adenomas, while progestin-only agents show less growth or even regression 2
  • Unopposed estrogens have been positively associated with adenocarcinomas in some studies 3
  • After menopause, hepatocellular adenomas tend to decrease in size, suggesting the role of hormonal influence 4

Physical Characteristics of Adenomas

  • Adenomas are soft, encapsulated and are tan to light brown in appearance 1
  • Pituitary adenomas can be identified by their characteristic appearance on MRI, with microadenomas (<10mm) typically seen as hypoenhancing lesions 1
  • Hepatocellular adenomas may show regression after menopause, with mean diameter decreasing significantly over time 4

Number and Distribution of Adenomas

  • Adenomas are typically solitary lesions 1
  • In cases where multiple adenomas are present, each should be separately characterized 5
  • Fibroadenomas (a type of adenoma) can constitute about 10% of all biopsies in postmenopausal women, but they are not the most common finding in this population 6

Clinical Implications

  • Prolactinomas, the most common type of pituitary adenoma, are exceptionally rare before puberty but more common in adolescence 1
  • Macroprolactinomas or giant prolactinomas occur more frequently in children and young people than in adults 1
  • Hepatocellular adenomas tend to regress after menopause, suggesting that routine follow-up may not be required for small (<5cm) adenomas in postmenopausal women 4

Remember that adenomas are not most commonly seen in menopausal women - they typically present earlier in life, with pituitary adenomas being more common in adolescence and hepatocellular adenomas often regressing after menopause.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Adnexal Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Occurrence of fibroadenomas in postmenopausal women referred for breast biopsy.

Journal of the American Geriatrics Society, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.